Filing Details
- Accession Number:
- 0001127602-12-012935
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-04-03 13:00:00
- Reporting Period:
- 2012-04-02
- Filing Date:
- 2012-04-03
- Accepted Time:
- 2012-04-03 16:20:59
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1022079 | Quest Diagnostics Inc | DGX | Services-Medical Laboratories (8071) | 161387862 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1222676 | Robert Hagemann | C/O Quest Diagnostics Incorporated 3 Giralda Farms Madison NJ 07940 | Svp & Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2012-04-02 | 46,666 | $40.43 | 201,232 | No | 4 | M | Direct | |
Common Stock | Disposition | 2012-04-02 | 46,666 | $62.00 | 154,566 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Options (Right to Buy) | Disposition | 2012-04-02 | 46,666 | $0.00 | 46,666 | $40.43 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
93,334 | 2014-02-19 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 1,771 | Indirect | SDCP |
Footnotes
- The options vested in three annual installments on February 19, 2005, February 19, 2006 and February 19, 2007.
- The exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on January 26, 2012.
- The amount includes exempt purchases made under the Company's stock purchase plan.
- These underlying shares were acquired on a periodic basis by the trustee of the Company's Supplemental Deferred Compensation Plan. The information was obtained from the plan administrator as of a recent date. The number of shares is based on the account balance of the Company stock fund under the plan (which includes some money market instruments), divided by the market price of the Company's stock as of that date.